EMAIL THIS PAGE TO A FRIEND

Arthritis research & therapy

Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.


PMID 24708674

Abstract

Although the pathogenesis of systemic sclerosis (SSc) still remains unknown, recent studies have demonstrated that endothelins are deeply involved in the developmental process of fibrosis and vasculopathy associated with SSc, and a dual endothelin receptor antagonist, bosentan, has a potential to serve as a disease modifying drug for this disorder. Importantly, endothelin-1 (ET-1) exerts a pro-fibrotic effect on normal dermal fibroblasts and bosentan reverses the pro-fibrotic phenotype of SSc dermal fibroblasts. The purpose of this study was to clarify the details of molecular mechanisms underlying the effects of ET-1 and bosentan on dermal fibroblasts, which have not been well studied. The mRNA levels of target genes and the expression and phosphorylation levels of target proteins were determined by reverse transcription real-time PCR and immunoblotting, respectively. Promoter assays were performed using a sequential deletion of human α2 (I) collagen (COL1A2) promoter. DNA affinity precipitation and chromatin immunoprecipitation were employed to evaluate the DNA binding ability of Fli1. Fli1 protein levels in murine skin were evaluated by immunostaining. In normal fibroblasts, ET-1 activated c-Abl and protein kinase C (PKC)-δ and induced Fli1 phosphorylation at threonine 312, leading to the decreased DNA binding of Fli1, a potent repressor of the COL1A2 gene, and the increase in type I collagen expression. On the other hand, bosentan reduced the expression of c-Abl and PKC-δ, the nuclear localization of PKC-δ, and Fli1 phosphorylation, resulting in the increased DNA binding of Fli1 and the suppression of type I collagen expression in SSc fibroblasts. In bleomycin-treated mice, bosentan prevented dermal fibrosis and increased Fli1 expression in lesional dermal fibroblasts. ET-1 exerts a potent pro-fibrotic effect on normal fibroblasts by activating "c-Abl - PKC-δ - Fli1" pathway. Bosentan reverses the pro-fibrotic phenotype of SSc fibroblasts and prevents the development of dermal fibrosis in bleomycin-treated mice by blocking this signaling pathway. Although the efficacy of bosentan for dermal and pulmonary fibrosis is limited in SSc, the present observation definitely provides us with a useful clue to further explore the potential of the upcoming new dual endothelin receptor antagonists as disease modifying drugs for SSc.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4501043
Anti-ABL antibody produced in rabbit, affinity isolated antibody
HPA027251
Anti-ABL1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA027280
Anti-ABL1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
HPA028409
Anti-ABL1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4501046
Anti-ABL1 antibody produced in rabbit, affinity isolated antibody
A9979
Anti-Aly antibody, Mouse monoclonal, clone 11G5, purified from hybridoma cell culture
SAB2701734
Anti-cdk7 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA007932
Anti-CDK7 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV03009
Anti-CDK7 antibody produced in rabbit, IgG fraction of antiserum
SAB2104125
Anti-CDK7 antibody produced in rabbit, affinity isolated antibody
SAB4500060
Anti-CDK7 antibody produced in rabbit, affinity isolated antibody
SAB1412435
ANTI-FLI1 antibody produced in mouse, clone 2A2, purified immunoglobulin, buffered aqueous solution
SAB1412436
ANTI-FLI1 antibody produced in mouse, clone 2G5, purified immunoglobulin, buffered aqueous solution
SAB1412437
ANTI-FLI1 antibody produced in mouse, clone 2D6, purified immunoglobulin, buffered aqueous solution
SAB1412438
ANTI-FLI1 antibody produced in mouse, clone 1H4, purified immunoglobulin, buffered aqueous solution
SAB1412439
ANTI-FLI1 antibody produced in mouse, clone 2F3, purified immunoglobulin, buffered aqueous solution
SAB1412503
ANTI-FLI1 antibody produced in mouse, clone 1G8, purified immunoglobulin, buffered aqueous solution
SAB1412563
ANTI-FLI1 antibody produced in mouse, clone 2C10, purified immunoglobulin, buffered aqueous solution
SAB1412564
ANTI-FLI1 antibody produced in mouse, clone 2E6, purified immunoglobulin, buffered aqueous solution
AV38096
Anti-FLI1 antibody produced in rabbit, IgG fraction of antiserum
SAB2100822
Anti-FLI1 antibody produced in rabbit, affinity isolated antibody
SAB4500946
Anti-FLI1 antibody produced in rabbit, affinity isolated antibody
SAB2104067
Anti-FLI1, (N-terminal) antibody produced in rabbit, affinity isolated antibody, lyophilized powder
HPA007084
Anti-FLII antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA008903
Anti-FLII antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2100823
Anti-FLII antibody produced in rabbit, affinity isolated antibody
B3773 Anti-Human IgG (Fc specific)−Biotin antibody, Mouse monoclonal, clone HP-6017, purified from hybridoma cell culture
SAB4300489
Anti-KIT (Ab-721) antibody produced in rabbit, affinity isolated antibody
SAB4300593
Anti-KIT (Ab-936) antibody produced in rabbit, affinity isolated antibody
GW21114 Anti-KIT antibody produced in chicken, affinity isolated antibody, buffered aqueous solution